Related Experiment Video
Updated: Sep 7, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Vitamin D analogs: mechanism of action and therapeutic applications
1Gene Regulation, Bone and Inflammation Research, Eli Lilly and Company, Lilly Corporate Center, Indianapolis IN-46285, USA. nagpal_sunil@lilly.com
Abstract:
The physiological VDR ligand, 1 alpha,25-dihydroxyvitamin D3, acts upon a wide variety of tissues and cells, both related to and unrelated to calcium and phosphate homeostasis. The noncalcemic actions of natural and synthetic VDR ligands are exemplified by their potent anti-proliferative, prodifferentiative and immunomodulatory activities. As a result, a VDR ligand is an approved drug for the topical treatment of psoriasis. A plethora of actions of 1 alpha,25-dihydroxyvitamin D3 in various systems have suggested wide clinical applications of VDR ligands in such diverse disease states as inflammation (rheumatoid arthritis, psoriatic arthritis), dermatological indications (psoriasis, photoaging and skin rejuvenation), osteoporosis, cancers (breast, prostate, colon, leukemia and myelodysplastic syndrome) and autoimmune diseases (multiple sclerosis, type I diabetes and systemic lupus erythematosus). VDR ligands have shown therapeutic potential in limited human clinical trials as well as in animal models of these diseases. Some of the VDR ligands have shown not only potent preventive but also therapeutic anabolic activities in animal models of osteoporosis. However, the use of VDR in above mentioned indications as well as in oral therapy for psoriasis and even topical therapy for severe psoriasis is hampered by its associated toxicity, namely hypercalcemia. New VDR ligands have been synthesized which exhibit greater specificity by retaining desirable properties, but with reduced calcemic potential. The discovery of novel vitamin D3 analogs along with an increased understanding of the biological functions and mechanisms of action of VDR are likely to result in improved treatments for responsive indications.
Insights
Vitamin D analogs, known as VDR ligands, show promise for treating various diseases beyond bone health, including inflammation and cancer. However, their use is limited by toxicity, leading to the development of safer, more specific compounds.
Area of Science:
- Endocrinology
- Dermatology
- Oncology
- Immunology
Background:
- Vitamin D receptor (VDR) ligands, like 1 alpha,25-dihydroxyvitamin D3, influence numerous cellular processes beyond calcium homeostasis.
- These noncalcemic actions include anti-proliferative, prodifferentiative, and immunomodulatory effects, with VDR ligands already approved for psoriasis treatment.
Purpose of the Study:
- To explore the broad therapeutic potential of VDR ligands in diverse diseases.
- To address the toxicity limitations of current VDR ligands and highlight the development of novel analogs.
Main Methods:
- Review of existing literature on VDR ligand actions and clinical applications.
- Analysis of preclinical and clinical trial data for various VDR ligand-responsive conditions.
- Examination of newly synthesized VDR analogs with improved specificity and reduced calcemic potential.
Main Results:
- VDR ligands demonstrate therapeutic potential in inflammatory diseases, dermatological conditions, osteoporosis, cancers, and autoimmune disorders.
- Preclinical studies show preventive and therapeutic anabolic effects in osteoporosis models.
- Despite toxicity concerns (hypercalcemia), novel VDR ligands with reduced calcemic effects are being developed.
Conclusions:
- VDR ligands offer a wide range of potential clinical applications due to their diverse biological activities.
- Development of novel, specific VDR analogs is crucial for overcoming toxicity and expanding therapeutic use.
- Further research into VDR mechanisms and analog development promises improved treatments for various diseases.
Related Concept Videos
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Inhibitors of Viral Protein Synthesis

